The Facts

  • Breast cancer is the second most common cancer in the UK after non-melanoma skin cancer and over 44,100 new cases are diagnosed every year
  • Breast cancer claims the lives of 12,500 women each year in the UK. Men can also get breast cancer but it is rare (around 335 cases are diagnosed each year)
  • Of those women diagnosed with breast cancer today, two-thirds are likely to survive for at least 20 years
  • For more information please visit http://www.breastcancercare.org.uk/

Our Money

  • It is hoped that the money raised by Richmond Pharmacology will help to improve the survival rates of women with breast cancer for years to come
  • Richmond Pharmacology Ltd is pleased to have raised over �120 for breast cancer
Some of the Richmond Team
Some of the Richmond Team

Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

Swiss Biotech Day 2025

5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event